Search Results
Search results for "Dr. Thomas P. Sakmar"
Results found for "Dr. Thomas P. Sakmar"
- đź“° GPCR Weekly News, September 4 to 10, 2023
This week's highlights: Dr. Yamina Berchiche, Founder and Director of Dr. Dr. Dr. Save these dates: September 22: Join us for the Dr. Subscribe to the Dr. GPCR Newsletter for more insights!
- Misread the Curve, Misjudge the Drug: Rethinking Antagonism in GPCR Pharmacology
This week in Terry’s Corner, Dr. DR curves shift to the right with no loss of maximal effect. Each subscription includes: Weekly deep dives from Dr.
- Regulators of G-protein signaling: essential players in GPCR signaling
Cell, 1997. 89(2): p. 251-61. https://pubmed.ncbi.nlm.nih.gov/9108480/ 2. Front Mol Neurosci, 2020. 13: p. 5. https://pubmed.ncbi.nlm.nih.gov/32038168/ 3. Cell, 2021. 184(4): p. 931-942.e18. https://pubmed.ncbi.nlm.nih.gov/33571431/ 6. J Neurosci, 2019. 39(42): p. 8291-8304. https://pubmed.ncbi.nlm.nih.gov/31308097/ 8. Genomics, 2021. 113(4): p. 2134-2144. https://pubmed.ncbi.nlm.nih.gov/33845140/
- đź“° GPCR Weekly News, July 3 to 9, 2023
Congratulations to Dr. Don't forget to mark your calendars for July 21st, as the upcoming Dr. Be sure to subscribe to Dr. GPCR Newsletter for updates! Industry News Dr. Associate Director / Director, Clinical Operations Professor in Cardiovascular Pharmacology Explore Dr
- Regulator of G Protein Signaling 20 Correlates with Long Intergenic Non-Coding RNA (lincRNAs)...
clinical parameters such as alpha-fetoprotein and tumor grade in the HCC patients; (c) besides HCC (p was found to be an important factor for survival in four other cancers (clear renal cell carcinoma: p < 0.001, lung adenocarcinoma: p = 0.004, mesothelioma: p = 0.039, ovarian serous cystadenocarcinoma: p = 0.048); (d) RGS20 was found to be significantly associated with some tumor-related signaling pathways
- The Perils and Guardrails of Modifying Signalling Proteins in Bioassays
Dr. Hunter P. Persechino M, Hedderich JB, Kolb P, Hilger D. Changeux J-P, Christopoulos A. González-Maeso J, Weisstaub NV, Zhou M, Chan P, Ivic L, Ang R, et al.
- Unlock the Hidden Complexity Behind GPCRs—From Terry Kenakin’s Vault
In the foundational lesson of Terry’s Corner , Dr.
- đź“° GPCR Weekly News, August 7 to 13, 2023
On September 22nd, we're hosting the Dr. GPCR Symposium on 'GPCRs as Therapeutic Modalities'. Make sure to stay in the loop with the Dr. GPCR Newsletter! Molecular Pharmacology Director, Clinical Data Management Director, Discovery Toxicology Postdoc Fellow - Dr Robert Lefkowitz Lab Postdoc Fellow - Dr. Robert Lefkowitz Lab Explore Dr. GPCR Ecosystem
- 🎄 Have Yourself a Merry Little GPCRmas! ❄ Dec 9 - 15, 2024
At Dr. Thank you for sharing your perspective and helping us shape the future of the Dr. GPCR ecosystem! Best, Yamina & the Dr.
- GPCR News Flash! Top Updates You Can't-Miss! + University CheatSheet is finally available! âť„ Dec 2 - 8, 2024
It's starting to look a lot like Christmas at Dr. GPCR! coupling between extracellular and transmembrane domains modulates holo-adhesion GPCR function Szymon P
- High GPER expression in triple-negative breast cancer is linked to pro-metastatic pathways and...
of patients showed high GPER expression and significant correlation with the mRNA subtype of TNBC (P  = 0.001), total metastatic events (P = 0.019) and liver metastasis (P = 0.011). interval of 67.1 months, a significant trend towards reduced distant metastasis-free survival (DMFS) (P 
- Nanobodies: New Dimensions in GPCR Signaling Research
J., Pardon, E., Casarosa, P., Chae, P. S., Devree, B. T., Rosenbaum, D. M., Thian, F. M., Manglik, A., Hu, J., Hu, K., Eitel, K., HĂĽbner, H., Pardon, E., Valant, C., Sexton, P. C., Gmeiner, P., Steyaert, J., Weis, W. I., Garcia, K. C., Wess, J., & Kobilka, B. K. (2013). D., Tworak, A., Watanabe, K., Pardon, E., Steyaert, J., Kandori, H., Katayama, K., Kiser, P.
- đź“° GPCR Weekly News, August 21 to 27, 2023
This week's highlights: Dr. Terence E. Protein-Biased Agonists for Intracellular Angiotensin Receptors Promote Collagen Secretion in Myofibroblasts' Dr September 22: Don't miss the Dr. GPCR Symposium on 'GPCRs as Therapeutic Modalities'. Subscribe to Dr. GPCR Newsletter to receive more insights! Director, Regulatory Affairs Research Scientist/Senior Scientist I - Molecular Pharmacology Explore Dr
- đź“° GPCR Weekly News, September 25 to October 1, 2023
This week's highlights: Drs. Dr. Did you know that as a premium member, you enjoy exclusive access to recorded talks from our Dr. Subscribe now to gain access to exclusive insights from Dr. GPCR Newsletter! Research Fellow Research Technician II - Surgery Post-Doc Research Associate Research Technician Explore Dr
- Ever Wondered How Drugs Are Discovered?
Step into the world of drug discovery with Dr.
- Unveiling GPCR Priming: The Hidden Synergy in Cellular Signalling
Proc Natl Acad Sci U S A, 2020. 117(35): p. 21723-21730. 2.   Proceedings of the National Academy of Sciences, 2017. 114(14): p. 3756-3761. 3.   Mol Pharmacol, 2017. 91(5): p. 533-544.
- đź“° GPCR Weekly News, October 23 to 29, 2023
Save the dates: November 17: Join our final Dr. Get the inside scoop by subscribing to our monthly Dr. GPCR Newsletter, and watch our latest video featuring Dr. Kathleen Caron. Pharmaceuticals In vivo Antibody Discovery Research Scientist In Vitro Biologist/Molecular Pharmacologist Explore Dr
- Pharmacological Properties and Function of PxOctβ3 Octopamine Receptor in Plutella xylostella (L.)
and an analysis using quantitative PCR showed that it was expressed at all developmental stages of P. of double-stranded RNA in an RNA interference assay indicated that PxOctβ3 regulates development in P. This study demonstrated the pharmacological properties and functions of PxOctβ3 in P. xylostella, thus
- đź“° GPCR Weekly News, July 10 to 16, 2023
This week's GPCR papers feature a publication by Dr. Robert J Lefkowitz. Join us tomorrow, July 21, in the Dr. Remember to subscribe to Dr. GPCR Newsletter for updates! Lab Clinical Trial Associate Research Scientist/Senior Scientist I - Molecular Pharmacology Explore Dr
- đź“° GPCR Weekly News, June 5 to 11, 2023
This week's GPCR papers feature publications from Drs. attention to some of our events and resources: Please mark your calendars for July 21st for our next Dr Stay updated with Dr. GPCR News by subscribing to our monthly newsletter. Our founder Dr. Yamina A. Associate Director / Director, Clinical Operations Postdoctoral Research Associate Lab Manager Explore Dr
- đź“° GPCR Weekly News, May 1 to 7, 2023
Save the date and join us next week, May 19th, 2023 for the Dr. Stay informed with the latest Dr. GPCR News by subscribing to our monthly newsletter. 2023 Neurocrine Biosciences Reports First Quarter 2023 Financial Results Find Therapeutics welcomes Dr Expectations, EPS Lags “As Precision Medicine is critical, we cannot think about one size fits all” Dr Scientist—Immuno-Oncology Convergent Research - Senior Scientist, Cell-Based Assay Development Explore Dr
- Orthosteric vs. Allosteric Interactions: The Silent Decider of Safety and Success
Dr. stay ahead of the science 🧠Content built for biotech, pharma & academia 💬 Live monthly AMA with Dr Kenakin   💎 $2999/year — one conference cost = 12 months of expert training  Premium Dr.
- đź“° GPCR Weekly News, June 12 to 18, 2023
This week's GPCR paper features an innovative publication by Dr. Silvio Gutkind. July 21st marks our next Dr. Showcase your research by contacting us at Hello@DrGPCR.com Stay informed with Dr. Glioblastoma Associate Director / Director, Clinical Operations Postdoctoral Research Associate Explore Dr
- đź§ Do you want to share your #GPCR knowledge?
Come to Dr. GPCR Ecosystem and create a course on your favorite #GPCR research, technique and more… Available for Dr
- Sign Up Now!
The program of the Dr. GPCR Summit from October 10th to the 16th is taking shape. Check it out today but first become a Dr. GPCR Ecosystem site member, which is free!
- From GPCR Data Chaos to Decisive Action
pattern again and again—across academia, biotech, and through close work with dozens of teams inside the Dr Real-Time Global Insight As founder of Dr.
- đź“° GPCR Weekly News, May 15 to 21, 2023
This week's GPCR papers feature a publication from Dr. Marta Filizola. Check it out! The Dr. For Dr. GPCR News, please subscribe to your monthly newsletter. Culture Scientist/Tissue Culture Manager Postdoctoral Researcher Director - Targeted Oncology Explore Dr
- A2A Fluorescent Competitive Binding: Advancing NanoBRET® Target Engagement for GPCR Drug Discovery
.; Simonelli, P.; Baraldi, P. A.; Gao, Z.; Matricon, P.; Eddy, M. T.; Carlsson, J.
- GPCR Therapeutics Expands Scientific Advisory Board
Dr. Michel Bouvier, Dr. Luisa Salter-Cid, Dr. Omar Nadeem and Dr.
- đź“° GPCR Weekly News, October 30 to November 4, 2023
Dr. analogues for real-time binding studies of orphan GPCR GPR3: Save the dates: November 17: Join our final Dr You don't want to miss out on our monthly Dr. GPCR Newsletter for exclusive content, check out our latest video featuring Dr. Kathleen Caron. Crinetics Pharmaceuticals Senior Director, In vitro pharmacology - Crinetics Pharmaceuticals Explore Dr











